Itorihenz 50mg Tablet contains Itopride, a prokinetic agent used primarily to treat gastrointestinal motility disorders. Itopride acts by enhancing acetylcholine release through dopamine D2 receptor antagonism and inhibiting acetylcholinesterase activity, thereby promoting gastric emptying and improving gastrointestinal motility. This medication is indicated for the management of symptoms associated with functional dyspepsia, including bloating, nausea, early satiety, and upper abdominal discomfort. Itorihenz is also effective in treating delayed gastric emptying and related conditions such as gastroesophageal reflux disease (GERD). The recommended dosage is one 50mg tablet taken orally, typically three times daily before meals, or as directed by a healthcare professional. Itorihenz is generally well tolerated; however, patients may experience side effects such as diarrhea, abdominal cramps, or dizziness. It is contraindicated in individuals with mechanical gastrointestinal obstruction, perforation, or hemorrhage. Caution is advised in patients with renal or hepatic impairment. Itorihenz should be used under medical supervision, especially when administered concomitantly with other medications affecting gastrointestinal motility. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes in managing functional gastrointestinal disorders.